Representative before the EPO

Employment test 51 - 200 employees
Company dna danubia patent and law office llc
operating since 1949
Headquarter in Budapest
active in Legal Services and IP Consulting

We have observed 27 EP applications Adam Svingor has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13168263

Dilution based inhibition assay

IPC classification:
G01N 33/50
Applicant:
University of Debrecen (Debreceni Egyetem)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION IN PROGRESS
EP12805746

PRODUCTION OF BIOGAS FROM PROTEIN-RICH RESOURCES

IPC classification:
C12P 39/00, C12P 5/02, C12N 1/36, C12N 1/20, C02F 11/04, C02F 3/34, C02F 3/28
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
PATENT GRANTED
EP12881084

A COMPOSITION COMPRISING REDUCED GLUTATHIONE AND ACETAMINOPHEN AND PREPARATION METHOD THEREOF

IPC classification:
A61K 38/06, A61K 31/167, A61K 9/48, A61K 9/20, A61K 9/16, A61K 9/107, A61K 9/08, A61P 39/02, A61P 25/04, A61P 1/16
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859997

VESICULAR STOMATITIS VIRUS FOR PRIME BOOST VACCINES

IPC classification:
A61K 39/295, A61K 39/205, C12N 15/47, C12N 7/01, C07K 14/145, A61P 37/04, A61P 31/14
Applicant:
University of Western Ontario (UWO)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
GRANT OF PATENT INTENDED
EP12860227

LOCKING TYPE PANEL AND PANEL CONNECTING PIECE AND CONNECTION METHOD THEREFOR

IPC classification:
E04F 15/02
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
GRANT OF PATENT INTENDED
EP12859367

APPARATUS FOR ON DEMAND LIMITING OF THE VALUE RANGE OF A PARAMETER ADJUSTMENT DEVICE

IPC classification:
H01C 10/00, G05G 5/02, G01R 17/20
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION REQUESTED
EP13712598

ABCG2 TRANSPORTER ASSAY

IPC classification:
G01N 33/566
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
PATENT GRANTED
EP13771919

FOOD GRADE BACTERIA FOR THE REMOVAL OF TOXIC COMPOUNDS

IPC classification:
A61K 35/74, A23L 1/30, A23L 1/015, A23K 1/16, A23C 9/12, C12N 15/00, C12N 1/20, B01D 53/84, A62D 3/02, A61P 39/00
Applicant:
London Health Sciences Centre Research Inc.
Applicant:
Compagnie Gervais Danone
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION IN PROGRESS
EP12843911

MODIFIED PEPTIDE TOXINS

IPC classification:
A61K 38/17, C07K 14/435, A61P 25/00, A61P 17/06, A61P 3/10
Applicant:
University of Szeged (University of Szeged)
Applicant:
University of Debrecen (Debreceni Egyetem)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION IN PROGRESS
EP12744116

TREATMENT AND PREVENTION OF DISEASES RELATED TO OXIDATIVE STRESS

IPC classification:
A61K 31/198, A61K 31/192, A23L 1/305, A61P 35/00, A61P 13/12, A61P 9/10, A61P 7/06, A61P 5/50, A61P 5/00, A61P 3/10, A61P 3/04
Applicant:
University of Pécs (University of Pécs)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14189856

A method for constructing a CD81 and OCLN double transgenic mouse

IPC classification:
A01K 67/027
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
The patent has been granted
EP13774827

RADIATION ABSORBING COMPOSITION

IPC classification:
G21F 1/10
Applicant:
Stavanger University Hospital (Stavanger Universitetssjukehus, Helse Stavanger)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
GRANT OF PATENT INTENDED
EP14001978

Botulinum toxin for use in the treatment of paratonia

IPC classification:
A61K 38/48, A61K 9/00, A61P 25/14
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
The patent has been granted
EP14707886

SERUM FRACTION OF PLATELET-RICH FIBRIN

IPC classification:
A61P 17/02, A61P 19/08, C12N 5/00, A61L 27/36, A61K 35/16
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION REQUESTED
EP14798200

EXPANDABLE CELL POPULATIONS FROM BRAIN BIOPSIES OF LIVING SUBJECTS

IPC classification:
C12Q 1/04, C12N 5/10, C12N 5/077, C12N 5/07, A61P 25/00, A61K 35/30, C12N 5/079
Applicant:
London Health Sciences Centre Research Inc.
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION REQUESTED
EP14799520

PROCESS FOR FEEDING FISH, FISH MEAT AND FOOD PRODUCT

IPC classification:
A23L 2/00
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
The patent has been granted
EP15744035

COMPOSITIONS AND METHODS FOR QUANTITATIVE ASSESMENT OF DNA-PROTEIN COMPLEX DENSITY

IPC classification:
C40B 30/04
Applicant:
University of Chicago
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION REQUESTED
EP15715809

NOVEL USE OF SIGMA-1 RECEPTOR AGONIST COMPOUNDS

IPC classification:
A61P 21/00, A61P 11/00, A61P 9/10, A61K 31/15, A61K 31/138, A61K 31/135
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
EXAMINATION REQUESTED
EP15172194

PORK MEAT PRODUCT OF IMPROVED FATTY ACID COMPOSITION

IPC classification:
A23K 10/40, A23K 10/00, A23L 13/40, A23L 13/00
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
APPLICATION PUBLISHED
EP16202263

IMPROVED METHOD AND SYSTEM FOR RENDERING ANIMAL FAT

IPC classification:
C11B 3/12, C11B 3/00, A23D 9/02
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP15828366

TRANSGENIC MOUSE FOR THE ASSESSMENT OF THYROID HORMONE (TH) ACTION

IPC classification:
C12N 15/85, A01K 67/027
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP15825825

ARYLALKYLAMINE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/343, A61K 31/137
Applicant:
Semmelweis University (Semmelweis Egyetem)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP15825824

ARYLALKYLAMINE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/137
Applicant:
Semmelweis University (Semmelweis Egyetem)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP15871379

PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT

IPC classification:
G01N 33/48, C12Q 1/68, C12Q 1/00, A61P 35/04, A61P 35/00, A61K 39/395
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP16767575

METABOLOMICS PROFILING OF CENTRAL NERVOUS SYSTEM INJURY

IPC classification:
G06F 19/00, G06F 15/18, G01N 33/483, A61B 5/00, G01N 33/48
Applicant:
London Health Sciences Centre Research Inc.
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP16791877

INTRATUMORAL MODULATION THERAPY

IPC classification:
A61N 1/36, A61N 1/20, A61N 1/05, A61N 1/18
Applicant:
London Health Sciences Centre Research Inc.
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made
EP16729373

STEREOSELECTIVE SYNTHESIS OF 9-CIS.13,14-DIHYDRORETINOIC ACID AND ITS ETHYL ESTERS

IPC classification:
C07C 403/20
Applicant:
Université de Strasbourg
Applicant:
University of Debrecen (Debreceni Egyetem)
Agent:
Adam Svingor, Danubia Patent and Law Office LLC
Status:
Request for examination was made

Please Sign in to use this feature